blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1771435

EP1771435 - MODULATORS OF CENTRAL NERVOUS SYSTEM NEUROTRANSMITTERS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.03.2016
Database last updated on 25.09.2024
Most recent event   Tooltip25.03.2016Application deemed to be withdrawnpublished on 27.04.2016  [2016/17]
Applicant(s)For all designated states
Human Biomolecular Research Institute
5310 Eastgate Mall
San Diego CA 92121 / US
[2007/15]
Inventor(s)01 / CASHMAN, John R.
5310 Eastgate Mall
San Diego, California 92121 / US
 [2007/15]
Representative(s)Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Ganghoferstraße 68 B
80339 München / DE
[N/P]
Former [2011/25]Schiweck, Weinzierl & Koch
European Patent Attorneys Landsberger Straße 98
80339 München / DE
Former [2010/13]Viering, Jentschura & Partner
Postfach 22 14 43
80504 München / DE
Former [2008/43]Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11
80538 München / DE
Former [2007/15]Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstraße 11
D-80538 München / DE
Application number, filing date05812931.320.06.2005
[2007/15]
WO2005US21818
Priority number, dateUS20040581210P19.06.2004         Original published format: US 581210 P
[2007/15]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006025920
Date:09.03.2006
Language:EN
[2006/10]
Type: A2 Application without search report 
No.:EP1771435
Date:11.04.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 09.03.2006 takes the place of the publication of the European patent application.
[2007/15]
Search report(s)International search report - published on:US17.08.2006
(Supplementary) European search report - dispatched on:EP11.01.2008
ClassificationIPC:C07D307/00, C07D317/00, A01N43/08, C07D405/04, C07D405/06, C07D323/02, A61K31/341, A61P25/22, A61P25/24
[2008/05]
CPC:
C07D307/14 (EP,US); C07D413/06 (US); A61P25/00 (EP);
A61P25/22 (EP); A61P25/24 (EP); C07D237/32 (US);
C07D405/04 (EP,US); C07D405/06 (EP,US); C07D405/12 (US) (-)
Former IPC [2007/15]C07D323/02, C07D307/00, C07D317/00, A01N43/08
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/15]
Extension statesAL15.01.2007
BA15.01.2007
HR15.01.2007
LV15.01.2007
MK15.01.2007
YU15.01.2007
TitleGerman:MODULATOREN VON NEUROTRANSMITTERN DES ZENTRALEN NERVENSYSTEMS[2007/15]
English:MODULATORS OF CENTRAL NERVOUS SYSTEM NEUROTRANSMITTERS[2007/15]
French:MODULATEURS DE NEUROTRANSMETTEURS DU SYSTEME NERVEUX CENTRAL[2007/15]
Entry into regional phase15.01.2007National basic fee paid 
15.01.2007Search fee paid 
15.01.2007Designation fee(s) paid 
15.01.2007Examination fee paid 
Examination procedure15.01.2007Examination requested  [2007/15]
22.02.2011Despatch of a communication from the examining division (Time limit: M06)
19.12.2011Reply to a communication from the examining division
22.06.2015Despatch of a communication from the examining division (Time limit: M04)
03.11.2015Application deemed to be withdrawn, date of legal effect  [2016/17]
03.12.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/17]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.02.2011
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
19.12.2011Request for further processing filed
19.12.2011Full payment received (date of receipt of payment)
Request granted
24.01.2012Decision despatched
Fees paidRenewal fee
14.06.2007Renewal fee patent year 03
27.06.2008Renewal fee patent year 04
16.06.2009Renewal fee patent year 05
11.06.2010Renewal fee patent year 06
13.06.2011Renewal fee patent year 07
14.06.2012Renewal fee patent year 08
27.06.2013Renewal fee patent year 09
30.06.2014Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
30.06.201511   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2857397  (COPE ARTHUR C) [X] 1,2 * column 1 - column 2 *;
 [X]EP0158922  (BAYER AG [DE]) [X] 1-4 * claim - *;
 [X]EP0289913  (BAYER AG [DE]) [X] 1-4,15,16 * examples 206-218,266; claim - *;
 [X]GB2268742  (SCRAS [FR]) [X] 1-3,15,16 * claim 21 *;
 [X]US6121307  (MEWSHAW RICHARD E [US], et al) [X] 13,15,16 * column 0; claim - *;
 [E]WO2005066162  (HUMAN BIOMOLECULAR RES INST [US], et al) [E] 1,2,15,16 * claim 13; tables 9,10; compounds 2,16,29,38 *;
 [X]  - ROBINS M J ET AL, "Nucleic acid related compounds. 114. Synthesis of 2,6-(disubstituted)purine 2',3'-dideoxynucleosides and selected cytotoxic, anti-hepatitis B and adenosine deaminase substrate activities", JOURNAL OF HETEROCYCLIC CHEMISTRY, HETERO CORP., TAMPA, FL, US, (200111), vol. 38, ISSN 0022-152X, pages 1297 - 1306, XP002952782 [X] 1,13 * compound 6C *

DOI:   http://dx.doi.org/10.1002/jhet.5570380609
 [X]  - SH. HARUSAWA ET AL., "synthesis of 4(5)-[5-(aminomethyl)tetrahydrofuran-2-yl- or 5-(aminomethyl)-2,5-dihydrofuran-2-yl]imidazoles by efficient use of a phse group:", JOURNAL OF ORGANIC CHEMISTRY., USAMERICAN CHEMICAL SOCIETY. EASTON., (1999), vol. 64, no. 23, pages 8608 - 8615, XP002463054 [X] 1,13,16 * page 8606 - page 8607 *

DOI:   http://dx.doi.org/10.1021/jo9910637
 [X]  - A. COPE, "preparation and reactions of quaternary ammonium salts derived from cis-2,5-bis-hydroxymethyl-tetrahydrofuran ditosylate.", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY., USAMERICAN CHEMICAL SOCIETY, WASHINGTON, DC., (19590905), vol. 81, pages 4577 - 4583, XP002463055 [X] 1,2 * page 4577 - page 4578; compounds VIII, X *

DOI:   http://dx.doi.org/10.1021/ja01526a035
 [X]  - ROBINSON, ROBERT ET AL, ".beta.-Phenylfurylethylamine and analogous derivatives of thiophene and pyrrole", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1940:6253, URL: STN, XP002463056 [X] 1,5 * abstract *
International search[X]US5010060  (LAMBERT ROBERT W [GB], et al);
 [X]US5583147  (KO SOO S [US], et al);
 [X]WO9706178  (HOFFMANN LA ROCHE [CH]);
 [X]US6472384  (INUKAI MASATOSHI [JP], et al);
 [X]  - RICHTER ET AL., "The Coordination of 5'-derivatives of adenosine to vanadate", INORGANICA CHIMICA, (1995), vol. 238, no. 1-2, pages 155 - 158, XP003001049

DOI:   http://dx.doi.org/10.1016/0020-1693(95)04700-J
 [X]  - BARALDI ET AL., "Novel N6-(Substituted-phenylcarbamoyl) adenosine-5'-uronamides as Potent Agonists for A3 Adenosine Receptors", J. MED. CHEM., (1996), vol. 39, pages 802 - 806, XP002913657

DOI:   http://dx.doi.org/10.1021/jm950518r
ExaminationUS6121307
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.